PMID: 9165384Apr 1, 1997Paper

Lithium versus carbamazepine in the maintenance treatment of bipolar disorders--a randomised study

Journal of Affective Disorders
W GreilT Wetterling

Abstract

In a randomised multicentre study, the prophylactic efficacy of lithium and carbamazepine was compared in 144 patients with bipolar disorder (74 vs. 70 patients; observation period: 2.5 years; lithium serum level: 0.63 +/- 0.12 mmol/l, carbamazepine dose: 621 +/- 186 mg/day). Hospitalisations, recurrences, need of psychotropic comedication and adverse effects prompting discontinuation were defined as treatment failures. Survival analyses regarding hospitalisations and recurrences showed no statistically significant differences between both drugs. Results were distinctly in favour of lithium, considering recurrences combined with comedication (P = 0.041) and/or adverse effects (P = 0.007). Whereas adverse effects prompting discontinuation were more frequent under carbamazepine (9 vs. 4, ns), lithium patients reported more often slight/moderate side effects (61% vs. 21% after 2.5 years; P = 0.0006). In completers, recurrences occurred in 28% (lithium) vs. 47% (carbamazepine) of the patients (P = 0.06). Lithium seems to be superior to carbamazepine in maintenance treatment of bipolar disorder, in particular when applying broader outcome criteria including psychotropic comedication and severe side effects.

References

May 1, 1976·The British Journal of Psychiatry : the Journal of Mental Science·A CoppenJ E Bailey
Feb 1, 1992·Acta Psychiatrica Scandinavica·N CoxheadJ Cookson
Nov 30, 1989·The New England Journal of Medicine·A J GelenbergJ Lavelle
Feb 1, 1987·The British Journal of Psychiatry : the Journal of Mental Science·S E WatkinsD M Shaw
Aug 1, 1988·The British Journal of Psychiatry : the Journal of Mental Science·R M LusznatC M Nunn
Jun 1, 1970·The British Journal of Psychiatry : the Journal of Mental Science·P GrofP Weis
Mar 1, 1995·The British Journal of Psychiatry : the Journal of Mental Science·R DardennesA Heim
Sep 1, 1994·The New England Journal of Medicine·L H Price, G R Heninger
Jan 1, 1993·Neuropsychobiology·R M PostK Denicoff
Jan 1, 1993·Neuropsychobiology·T Okuma
Jan 1, 1993·International Clinical Psychopharmacology·S A Montgomery, G Dunbar
Jan 1, 1997·European Archives of Psychiatry and Clinical Neuroscience·W GreilT Wetterling

❮ Previous
Next ❯

Citations

Jan 1, 1997·European Archives of Psychiatry and Clinical Neuroscience·W GreilT Wetterling
May 25, 2012·European Archives of Psychiatry and Clinical Neuroscience·Konstantinos N FountoulakisEduard Vieta
Jun 11, 2005·Progress in Neuro-psychopharmacology & Biological Psychiatry·Martin AldaL Trevor Young
Jan 29, 2002·Lancet·Bruno Müller-OerlinghausenMichael Bauer
Jan 1, 2003·Journal of Affective Disorders·Paul E Keck, Susan L McElroy
Feb 19, 2003·Journal of Affective Disorders·Jonathan S E Hellewell
Feb 19, 2003·Journal of Affective Disorders·Heinz Grunze, Jörg Walden
Jun 23, 2005·Molecular Psychiatry·G M MacQueenM Alda
Apr 7, 2007·International Clinical Psychopharmacology·Nikolaus KleindienstWaldemar Greil
Jan 6, 2000·The Australian and New Zealand Journal of Psychiatry·W Z Potter, M E Ozcan
May 18, 2004·The Australian and New Zealand Journal of Psychiatry·UNKNOWN Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines Team for Bipolar Disorder
May 11, 2006·The Australian and New Zealand Journal of Psychiatry·Charles L Bowden, Nancy U Karren
May 18, 2005·Psychiatry and Clinical Neurosciences·Michael BerkLesley Berk
Jun 23, 2005·Epilepsia·Prashant GajwaniHeinz Grunze
Jul 21, 1998·Acta Psychiatrica Scandinavica·R W Licht
Jan 8, 2000·Acta Psychiatrica Scandinavica·J M DavisD M Hogan
Oct 11, 2007·Annals of General Psychiatry·Konstantinos N FountoulakisGeorge S Kaprinis
May 1, 2001·Suicide & Life-threatening Behavior·A Roy
Dec 7, 2002·CNS Drugs·Gin S MalhiShahzad Salim
May 20, 2003·CNS Drugs·Leonardo TondoRoss Baldessarini
Jan 7, 2006·CNS Drugs·Daniel LinLakshmi N Yatham
Jul 17, 2007·CNS Drugs·Ana González-PintoCristina González Gómez
Feb 2, 2013·Indian Journal of Psychiatry·Rajiv Radhakrishnan, Chittaranjan Andrade
Mar 20, 2001·Bipolar Disorders·R S El-Mallakh
Sep 5, 2001·Acta Psychiatrica Scandinavica·A J Gelenberg
Nov 28, 2001·Acta Psychiatrica Scandinavica·R W LichtP E Hansen
Sep 5, 2001·Acta Psychiatrica Scandinavica·L TondoR J Baldessarini
Dec 21, 2000·Journal of Affective Disorders·S A MontgomeryJ Zajecka
Dec 21, 2000·Journal of Affective Disorders·C L Bowden von Knorring L
Dec 21, 2000·Journal of Affective Disorders·S A Montgomery, P E Keck
Oct 8, 1999·Journal of Affective Disorders·J MendlewiczS K Rivelli
Jul 26, 2005·Archives of Suicide Research : Official Journal of the International Academy for Suicide Research·Erik LauterbachFritz Hohagen
Jul 16, 2005·Archives of Suicide Research : Official Journal of the International Academy for Suicide Research·Jules AngstAlex Gamma
Jul 16, 2005·Archives of Suicide Research : Official Journal of the International Academy for Suicide Research·Bruno Müller-OerlinghausenBernd Ahrens
Mar 3, 2009·World Journal of Surgery·Brian D SaundersPaul G Gauger

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.